Learn more about the latest research and treatments for HER2-positive breast cancer. Ian Krop, MD, PhD, discusses new advances in treating this disease, including research in drug resistance. Krop is the director of clinical research in the Breast Oncology Program at the Susan F. Smith Center for Women's Cancers at Dana-Farber.
This presentation was originally given at the Susan F. Smith Center Executive Council Breakfast on April 16, 2015.
For more information: visit www.susanfsmith.org.